Profits over Patient Safety: Pradaxa TV Commercials Continue To Flood The Networks
Steps taken by the international pharmaceutical corporation Boehringer Ingelheim pursuant to the development of Pradaxa, an FDA – approved prescription medicine designed to help reduce the risk of stroke in persons with nonvalvular atrial fibrillation, demonstrate the company’s purely profit – driven motivation with respect to the drugs distribution. Moreover, Pradaxa is expected to be […]
Pradaxa has Woefully Inadequate Warnings and Precautions About Serious Bleeding Risks
Despite the serious risks associated with daily usage of Pradaxa, Boehringer Ingelheim, the drugs creator, fails to adequately warn patients of the dangers involved. Evidence of this claim is demonstrated when reviewing a study issued by the Institute for Safe Medication Practices, which reported that out of the 272,119 prescriptions issued for Pradaxa in the […]
Pradaxa Side Effects Outweigh Any Supposed Benefit In Terms of Patient Safety
While Pradaxa, a recently developed oral anticoagulant intended to combat the risk of stroke in patients with atrial fibrillation (AF), was created with an eye to sidestepping many of the limitations associated with Warfarin, Pradaxa’s main competitor, new and potentially more dangerous hazards have arisen with respect to its prescription. Boehringer Ingelheim, the international pharmaceutical […]
15-year Danish Study Shows that Yaz, Yasmin and Ocella increase the Risk of Thrombotic Stroke
In a recent article published by the New England Journal of Medicine, a 15-year Danish cohort study assessed the risk of thrombotic stroke and myocardial infarction associated with the hormonal contraception. Data was collected from nonpregnant women, ages 15 to 49 without a history of cancer or cardiovascular disease. Oral contraceptives that contained 30 to […]
Pradaxa riks of bleeding death greater than Warfarin because Pradaxa has no antidote
Despite recent advances in heart patient medications, research has been shown that those prescribed Pradaxa are at greater risk of deadly side effects than risks posed by its predecessor, Warfarin. Intended to prevent strokes in patients with an irregular heartbeat called atrial fibrillation, Pradaxa was designed to circumvent the possibility of brain hemorrhages and other […]
Pradaxa side effects including hemorrhage surpass all drugs monitored by FDA
According to data recently released from QuarterWatch, an Institute for Safe Medication Practices surveillance program which monitors all serious and fatal adverse drug events (ADEs) reported to the Food and Drug Administration through Medwatch, in 2011 the FDA received 179,855 reports of serious or fatal adverse drug reactions. This was an increase of 15,386 reports […]
J&J Irresponsibly Fails to Recall Vaginal Mesh Implants
In response to an increase in the amount of reported injuries and lawsuits resulting from surgical mesh implants, Johnson & Johnson has decided to stop selling the product used to treat women’s health problems. The company expressed its desire to do so in a letter sent to judges in New Jersey and West Virginia who […]
Canadian Study Finds an 83% Increased Risk of Bladder Cancer in Actos Users
In a new Canadian study recently published in the British Medical Journal on the side effects of Actos, it was reported that people being treated for type 2 diabetes with Takeda Pharmaceutical’s drug Actos may be putting themselves at risk for bladder cancer. Lead researcher Laurent Azoulay and her team colleted data on 115,727 patients […]
J&J Subsidiary Ethicon To Stop Selling Dangerous Vaginal Mesh Products
Johnson & Johnson subsidiary Ethicon announced today that it will cease marketing most of its vaginal mesh products. This announcement was made in two letters sent to the judges who are coordinating the Federal Multi-District Transvaginal Mesh Litigation in West Virginia, and in the coordinated New Jersey State Court Litigation. The company will be informing […]
United States District Court in West Virginia Prepares for the First Trial on Vaginal Mesh Implant Injuries
An August 2011 FDA report found that vaginal-mesh implants should be classified as high-risk to the more than 75,000 women who have them inserted annually. Makers of the devices, including Johnson & Johnson, have been ordered by the FDA to do multi-year studies related to the injuries associated with the implants. As the litigation of […]
